Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Adenosine A1 receptor activator T62

Copy Product Info
😃Good
Catalog No. T14127Cas No. 40312-34-3

Adenosine A1 receptor activator T62 is an allosteric enhancer of the adenosine A1 receptor, producing antinociception in animal models of acute pain and reducing hypersensitivity in models of inflammatory and nerve-injury pain[1][2][3].

Adenosine A1 receptor activator T62

Adenosine A1 receptor activator T62

Copy Product Info
😃Good
Purity: 97.83%
Catalog No. T14127Cas No. 40312-34-3
Adenosine A1 receptor activator T62 is an allosteric enhancer of the adenosine A1 receptor, producing antinociception in animal models of acute pain and reducing hypersensitivity in models of inflammatory and nerve-injury pain[1][2][3].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$62In StockIn Stock
5 mg$135In StockIn Stock
10 mg$201In StockIn Stock
25 mg$323In StockIn Stock
50 mg$441In StockIn Stock
100 mg$596In StockIn Stock
200 mg$791-In Stock
1 mL x 10 mM (in DMSO)$207In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.83%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Adenosine A1 receptor activator T62 is an allosteric enhancer of the adenosine A1 receptor, producing antinociception in animal models of acute pain and reducing hypersensitivity in models of inflammatory and nerve-injury pain[1][2][3].
In vivo
Intrathecal administration of the adenosine A1 receptor activator T62 (0.3-3 μg) in male Sprague-Dawley rats produces a dose-dependent antihypersensitivity effect without affecting ambulation or activity levels[1].
Animal Research
Intrathecal T62 of Male SpragueDawley rats (250 g) after paw incision surgery with the dose of 0.3 μg, 0.5 μg, 1 μg, and 3 μg, produced a dose-dependent antihypersensitivity effect, with no effect on ambulation or activity level. The ED40 (95% confidence interval) for T62 was 0.77 (0.63-0.91) microg.
Chemical Properties
Molecular Weight291.8
FormulaC15H14ClNOS
Cas No.40312-34-3
SmilesNc1sc2CCCCc2c1C(=O)c1ccc(Cl)cc1
Relative Density.1.337 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 75 mg/mL (257.03 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4270 mL17.1350 mL34.2700 mL171.3502 mL
5 mM0.6854 mL3.4270 mL6.8540 mL34.2700 mL
10 mM0.3427 mL1.7135 mL3.4270 mL17.1350 mL
20 mM0.1714 mL0.8568 mL1.7135 mL8.5675 mL
50 mM0.0685 mL0.3427 mL0.6854 mL3.4270 mL
100 mM0.0343 mL0.1714 mL0.3427 mL1.7135 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Adenosine A1 receptor activator T62 | purchase Adenosine A1 receptor activator T62 | Adenosine A1 receptor activator T62 cost | order Adenosine A1 receptor activator T62 | Adenosine A1 receptor activator T62 chemical structure | Adenosine A1 receptor activator T62 in vivo | Adenosine A1 receptor activator T62 formula | Adenosine A1 receptor activator T62 molecular weight